세계의 C형 간염 검사 시장 보고서(2025년)

Hepatitis C testing involves diagnostic techniques used to detect HCV infection or the body's immune response to it. These tests identify both current and past infections, enabling timely treatment. They are especially important for high-risk individuals and assist in monitoring treatment effectiveness. Early diagnosis helps reduce the risk of serious liver complications like cirrhosis and liver cancer.

The primary types of hepatitis C testing include antibody tests, nucleic acid tests, and genotyping tests. Antibody tests detect antibodies in the blood, indicating either a past or ongoing immune response to infections such as hepatitis C. The testing products encompass kits, instruments, reagents, and consumables that utilize various technologies like enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), and next-generation sequencing (NGS). These tests are used in applications such as blood screening, viral load monitoring, and disease diagnosis, and serve end-users including hospital laboratories, stand-alone labs, and others.

The hepatitis C testing market research report is one of a series of new reports from The Business Research Company that provides hepatitis C testing market statistics, including the hepatitis C testing industry global market size, regional shares, competitors with the hepatitis C testing market share, detailed hepatitis C testing market segments, market trends, opportunities, and any further data you may need to thrive in the hepatitis C testing industry. This hepatitis C testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hepatitis C testing market size has grown strongly in recent years. It will grow from $1.24 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be credited to the increasing prevalence of hepatitis C, the expansion of public health initiatives, a rise in intravenous drug use, heightened awareness of hepatitis C risks, and increased government funding for infectious disease control.

The hepatitis C testing market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing demand for early disease detection, expanded access to healthcare, a stronger focus on preventive healthcare, support from global health organizations, and government initiatives aimed at hepatitis C elimination. Key trends expected during this period include the adoption of multiplex diagnostic platforms, incorporation of artificial intelligence (AI) in diagnostic tools, a move toward home-based testing kits, enhanced collaboration in test development, and the creation of affordable testing solutions.

The increasing prevalence of hepatitis cases is expected to drive the growth of the hepatitis C testing market moving forward. Hepatitis C is a viral infection that causes liver inflammation and can result in severe liver damage if untreated. The rise in hepatitis cases is largely due to low vaccination rates, leaving many people vulnerable and enabling the virus to spread. Hepatitis C testing enables early detection of the virus, allowing timely treatment to prevent liver damage and serious complications. It also helps identify infected individuals to curb transmission and improve disease management. For example, in April 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental agency responsible for global public health, reported that over 50 million people worldwide are living with chronic hepatitis C infection, with roughly 1.0 million new cases annually. Thus, the increasing prevalence of hepatitis cases is fueling the growth of the hepatitis C testing market.

Leading companies in the hepatitis C testing market are focusing on developing advanced solutions like dual antigen-antibody diagnostic tests to improve screening and monitoring of the infection. These tests detect viral proteins (antigens) as well as immune response proteins (antibodies), allowing identification of both active and past infections. This dual detection method provides a comprehensive assessment of infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based provider of diagnostic tests and systems, launched Elecsys HCV Duo-a fully automated immunoassay that simultaneously and independently detects both HCV antigens and antibodies from a single plasma or serum sample. This innovation facilitates early diagnosis, aids patient management, and supports India's national goal to eliminate hepatitis C through timely and thorough screening.

In June 2022, Liver Care Canada, a healthcare organization focused on liver disease management, partnered with HepCURE Inc. to eliminate hepatitis C in Canada by 2030. This collaboration seeks to incorporate HepCURE's hepatitis C screening and treatment programs into Liver Care Canada's services, aiming to improve medication adherence, enhance patient outcomes, and increase access to care in underserved communities. HepCURE Inc., a Canadian non-profit organization dedicated to hepatitis C diagnosis and treatment, has demonstrated a 91% diagnosis rate and 80% linkage to care in Vancouver with its model.

Major players in the hepatitis C testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, and BIOGENIX INC. PVT. LTD.

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis C testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hepatitis C testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hepatitis C testing market consists of revenues earned by entities by providing services such as laboratory-based HCV RNA testing, rapid diagnostic tests, and home-based HCV test kits. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis C testing market also includes sales of quality control materials, sample collection devices, and point-of-care (POC) diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis C Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis c testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis c testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis c testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Antibody Tests; Nucleic Acid Tests; Genotyping Tests
• 2) By Product: Test Kits; Instruments; Reagents; Consumables
• 3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests; Polymerase Chain Reaction; Next-Generation Sequencing
• 4) By Application: Blood Screening; Viral Load Monitoring; Disease Diagnosis
• 5) By End-User: Hospital-Based Laboratories; Stand-Alone Laboratories; Other End-Users
• Subsegments:
• 1) By Antibody Tests: Enzyme Immunoassay (EIA); Recombinant Immunoblot Assay (RIBA); Rapid Diagnostic Tests (RDTs)
• 2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests; Qualitative Ribonucleic Acid (RNA) Tests; Transcription-Mediated Amplification (TMA); Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• 3) By Genotyping Tests: Line Probe Assay (LiPA); Sequencing-Based Assay; Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hepatitis C Testing Market Characteristics

3. Hepatitis C Testing Market Trends And Strategies

4. Hepatitis C Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hepatitis C Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hepatitis C Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hepatitis C Testing Market Growth Rate Analysis
• 5.4. Global Hepatitis C Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hepatitis C Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hepatitis C Testing Total Addressable Market (TAM)

6. Hepatitis C Testing Market Segmentation

• 6.1. Global Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Tests
• Nucleic Acid Tests
• Genotyping Tests
• 6.2. Global Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Test Kits
• Instruments
• Reagents
• Consumables
• 6.3. Global Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests
• Polymerase Chain Reaction
• Next-Generation Sequencing
• 6.4. Global Hepatitis C Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Screening
• Viral Load Monitoring
• Disease Diagnosis
• 6.5. Global Hepatitis C Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital-Based Laboratories
• Stand-Alone Laboratories
• Other End-Users
• 6.6. Global Hepatitis C Testing Market, Sub-Segmentation Of Antibody Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme Immunoassay (EIA)
• Recombinant Immunoblot Assay (RIBA)
• Rapid Diagnostic Tests (RDTs)
• 6.7. Global Hepatitis C Testing Market, Sub-Segmentation Of Nucleic Acid Tests (NATs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quantitative Ribonucleic Acid (RNA) Tests
• Qualitative Ribonucleic Acid (RNA) Tests
• Transcription-Mediated Amplification (TMA)
• Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• 6.8. Global Hepatitis C Testing Market, Sub-Segmentation Of Genotyping Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Line Probe Assay (LiPA)
• Sequencing-Based Assay
• Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

7. Hepatitis C Testing Market Regional And Country Analysis

• 7.1. Global Hepatitis C Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hepatitis C Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hepatitis C Testing Market

• 8.1. Asia-Pacific Hepatitis C Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hepatitis C Testing Market

• 9.1. China Hepatitis C Testing Market Overview
• 9.2. China Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hepatitis C Testing Market

• 10.1. India Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hepatitis C Testing Market

• 11.1. Japan Hepatitis C Testing Market Overview
• 11.2. Japan Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hepatitis C Testing Market

• 12.1. Australia Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hepatitis C Testing Market

• 13.1. Indonesia Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hepatitis C Testing Market

• 14.1. South Korea Hepatitis C Testing Market Overview
• 14.2. South Korea Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hepatitis C Testing Market

• 15.1. Western Europe Hepatitis C Testing Market Overview
• 15.2. Western Europe Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hepatitis C Testing Market

• 16.1. UK Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hepatitis C Testing Market

• 17.1. Germany Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hepatitis C Testing Market

• 18.1. France Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hepatitis C Testing Market

• 19.1. Italy Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hepatitis C Testing Market

• 20.1. Spain Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hepatitis C Testing Market

• 21.1. Eastern Europe Hepatitis C Testing Market Overview
• 21.2. Eastern Europe Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hepatitis C Testing Market

• 22.1. Russia Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hepatitis C Testing Market

• 23.1. North America Hepatitis C Testing Market Overview
• 23.2. North America Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hepatitis C Testing Market

• 24.1. USA Hepatitis C Testing Market Overview
• 24.2. USA Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hepatitis C Testing Market

• 25.1. Canada Hepatitis C Testing Market Overview
• 25.2. Canada Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hepatitis C Testing Market

• 26.1. South America Hepatitis C Testing Market Overview
• 26.2. South America Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hepatitis C Testing Market

• 27.1. Brazil Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hepatitis C Testing Market

• 28.1. Middle East Hepatitis C Testing Market Overview
• 28.2. Middle East Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hepatitis C Testing Market

• 29.1. Africa Hepatitis C Testing Market Overview
• 29.2. Africa Hepatitis C Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hepatitis C Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hepatitis C Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hepatitis C Testing Market Competitive Landscape And Company Profiles

• 30.1. Hepatitis C Testing Market Competitive Landscape
• 30.2. Hepatitis C Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Hepatitis C Testing Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Hologic Inc.
• 31.3. QuidelOrtho Corporation
• 31.4. Sysmex Corporation
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. SD Biosensor INC.
• 31.7. QIAGEN N.V.
• 31.8. DiaSorin S.p.A.
• 31.9. Cepheid
• 31.10. Abcam Plc
• 31.11. OraSure Technologies Inc.
• 31.12. Meridian Bioscience Inc.
• 31.13. Trivitron Healthcare Private Limited
• 31.14. General Biologicals Corporation
• 31.15. Biogate Laboratories Ltd.

32. Global Hepatitis C Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hepatitis C Testing Market

34. Recent Developments In The Hepatitis C Testing Market

35. Hepatitis C Testing Market High Potential Countries, Segments and Strategies

• 35.1 Hepatitis C Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hepatitis C Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hepatitis C Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer